Article Text
Statistics from Altmetric.com
QUESTION: In patients with non-diabetic renal disease, what is the effectiveness of the angiotensin II receptor blocker (ARB) losartan, the angiotensin converting enzyme (ACE) inhibitor trandolapril, or the 2 drugs combined for delaying disease progression?
Design
Randomised (unclear allocation concealment*), blinded (clinicians, patients, data collectors, and monitoring committee),* controlled trial with 3 years of follow up.
Setting
Hospital outpatient renal clinic serving 3 cities in Japan.
Patients
301 patients 18–70 years of age who had chronic non-diabetic renal insufficiency, persistent proteinuria, and no history of allergic reaction to drugs. Exclusion criteria included immediate need for renal replacement therapy; need for corticosteroids, non-steroidal anti-inflammatory drugs, or immunosuppressive drugs; proteinuria >10 g/day and hypoalbuminaemia <28 g/l; other serious disease; and pregnancy or breastfeeding. 263 patients …
Footnotes
-
Source of funding: in part, Ministry of Health, Labour, and Welfare, Japan.
-
For correspondence: Dr N Nakao, Showa University, Yokohama, Japan. lancetjp{at}yahoo.co.jp
-
Abstract and commentary also appear in ACP Journal Club.